Cytosorbents Corp
CTSO
34 hedge funds and large institutions have $8.06M invested in Cytosorbents Corp in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 7 closing their positions.
133% more capital inflows, than outflows
Capital inflows: $3.03M | Capital outflows: $1.3M
41% more call options, than puts
Call options by funds: $158K | Put options by funds: $112K
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
3% more funds holding
Funds holding: 33 → 34 (+1)
1.43% more ownership
Funds ownership: 5.54% → 6.97% (+1.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Raymond James & Associates
St Petersburg,
Florida
|
+$1.08M |
| 2 |
Douglass Winthrop Advisors
New York
|
+$307K |
| 3 |
BlackRock Fund Advisors
San Francisco,
California
|
+$66.1K |
| 4 |
Virtu KCG Holdings
New York
|
+$57.2K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$28.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIG
American International Group
New York
|
-$1.06M |
| 2 |
Credit Suisse
Zurich,
Switzerland
|
-$100K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$65.1K |
| 4 |
Advisory Services Network
Atlanta,
Georgia
|
-$25K |
| 5 |
Skylands Capital
Milwaukee,
Wisconsin
|
-$18K |
CTSO Hedge Fund Activity: Q2 2016 in Review
34 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q2 2016, worth a combined $8.06M — up 46% from $5.51M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CTSO positions and 7 closed out — a net gain of 2 holders — while 8 added to existing stakes and 6 trimmed.
The largest buyer was Raymond James & Associates, adding an estimated $1.08M. The largest seller was American International Group, exiting entirely with an estimated $1.06M sold.
- 34 institutional investors held Cytosorbents Corp (CTSO) as of Q2 2016, up from 33 in Q1 2016.
- Funds reported $8.06M of Cytosorbents Corp stock for Q2 2016, up 46% quarter-over-quarter.
- 9 funds opened new Cytosorbents Corp positions in Q2 2016 and 7 closed out, a net change of +2 holders.
- The largest Cytosorbents Corp buyer in Q2 2016 was Raymond James & Associates, an estimated $1.08M added.
- The largest Cytosorbents Corp seller in Q2 2016 was American International Group, an estimated $1.06M sold.
Based on aggregated 13F filings for Q2 2016.